My Top Value Stock to Buy for 2026 (and It’s Not Even Close)
Key Points There is a surprising amount of debate over the difference between value stocks and growth stocks.…
Market Trends: Will stock-specific trading continue to drive market gains?
Mumbai: India’s equity indices eked out gains on Friday after early losses as the optimism around the Reserve…
New lowest* point for NEM-wide Market Demand on Saturday 4th October 2025?
Posted by Paul McArdleSaturday 4th October 2025Â 10:57 AMÂ Â Topic: 2025-10-04 Another short morning article with a snapshot…
Why Quant MF faltered and how to invest in 2025: Chirag Muni explains
Indian markets have had a rough ride in 2025, with Nifty barely up 4% while gold and silver…
US shutdown, gold rallies and Hang Seng challenges 27,000 | Market Navigator
The week ahead This week delivers critical insights into US labour market resilience and consumer confidence, alongside corporate…
Bitcoin Pressures $120K as Traders Brace for Potential Short Squeeze
Bitcoin BTC$122,402.92 is continuing to chip away at a key level of resistance at $120,000 as it sets…
US markets mixed amid absence of economic data
The US government shutdown continues; employment data not presented According to CNBC, the US Senate has failed again…
No NFP and Hamas accepts the deal, but… – Market wrap for the North American session
The political spotlight this weekend is on Japan, where the LDP Presidential Election (Friday, Oct 3) continues to…
Magnificent Seven surpass EU GDP: Is this a tech bubble warning?
ADVERTISEMENT The combined market value of the United States’ Magnificent Seven tech giants has now exceeded the entire…
US soft landing expected: Will interest rate cuts further stimulate the market rally?
The stock market outlook remains attractive, with US technology, emerging markets and Japanese stocks showing promise MARKETS previously…
IPO News – US IPO Weekly Winners & Losers
News from Washington halted the 2025 IPO market just as it was taking off. Again. The US “government…
Pharmaceutical Excipients Outlook 2025–2032: Strong CAGR of 8.4% with USD 19.29 Billion Valuation
The Global Pharmaceutical Excipients Market is estimated to be valued at USD 10.96 Bn in 2025 and is expected to reach USD…